This opportunity is no longer accepting applications.
grant PAR-23-083

Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)

This grant opportunity aims to support research that collects initial data for testing new treatments, both drug-based and non-drug-based, for cognitive and mental health changes related to age-related cognitive decline, Alzheimer's, and similar dementias. It also seeks to encourage studies that improve how these trials are designed and conducted.

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Aging
Program: SBIR

Awards & funding

Award Ceiling: $325,000
Award Amount: $325,000

Dates

Opportunity Released: December 23, 2022
Open for Submission: December 23, 2022
Submission Deadline: November 18, 2024
Application Window Closes: November 18, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.